Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;188(11):3153-3161.
doi: 10.1002/ajmg.a.62957. Epub 2022 Aug 18.

Analysis of COL7A1 pathogenic variants in a large cohort of dystrophic epidermolysis bullosa patients from Argentina reveals a new genotype-phenotype correlation

Affiliations

Analysis of COL7A1 pathogenic variants in a large cohort of dystrophic epidermolysis bullosa patients from Argentina reveals a new genotype-phenotype correlation

Mónica Inés Natale et al. Am J Med Genet A. 2022 Nov.

Abstract

Dystrophic epidermolysis bullosa (DEB) is a clinically heterogeneous heritable skin disorder, characterized by blistering of the skin and mucous membranes following minor trauma. Dominant (DDEB) and recessive (RDEB) forms are caused by pathogenic variants in COL7A1 gene. Argentina's population has a heterogeneous genetic background, and little is known about the molecular basis of DEB in our country or in native South American populations. In this study, we present the prevalence and geographical distribution of pathogenic variants found in 181 patients from 136 unrelated families (31 DDEB and 105 RDEB). We detected 95 different variants, 59 of them were previously reported in the literature and 36 were novel, nine of which were detected in more than one family. The most prevalent pathogenic variants were identified in exon 73 in DDEB patients and in exon 3 in RDEB patients. We also report a new phenotype-genotype correlation found in 10 unrelated families presenting mild blistering and severe mucosal involvement. Molecular studies in populations with an unexplored genetic background like ours revealed a diversity of pathogenic variants, and we hope that these findings will contribute to the definition of targets for new gene therapies.

Keywords: COL7A1; dystrophic epidermolysis bullosa; genodermatosis.

PubMed Disclaimer

References

REFERENCES

    1. Ashton, G. H., Mellerio, J. E., Dunnill, M. G., Milana, G., Mayou, B. J., Carrera, J., McGrath, J. A., & Eady, R. A. (1999). Recurrent molecular abnormalities in type VII collagen in southern Italian patients with recessive dystrophic epidermolysis bullosa. Clinical and Experimental Dermatology, 24(3), 232-235. https://doi.org/10.1046/j.1365-2230.1999.00461.x
    1. Bruckner-Tuderman, L. (1999). Hereditary skin diseases of anchoring fibrils. Journal of Dermatological Science, 20(2), 122-133.
    1. Bruckner-Tuderman, L., & Has, C. (2012). Molecular heterogeneity of blistering disorders: The paradigm of epidermolysis bullosa. The Journal of Investigative Dermatology, 132(E1), E2-E5. https://doi.org/10.1038/skinbio.2012.2
    1. Bruckner-Tuderman, L., Höpfner, B., & Hammami-Hauasli, N. (1999). Biology of anchoring fibrils: Lessons from dystrophic epidermolysis bullosa. Matrix Biology: Journal of the International Society for Matrix Biology, 18(1), 43-54.
    1. Christiano, A. M., Hoffman, G. G., Zhang, X., Xu, Y., Tamai, Y., Greenspan, D. S., & Uitto, J. (1997). Strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa. Human Mutation, 10(5), 408-414. https://doi.org/10.1002/(SICI)1098-1004(1997)10:5<408::AID-HUMU12>...

LinkOut - more resources